Leukemia-associated antigens such as proteins encoded by MAGE genes might provide tools for immunotherapy of leukemia. Positive and negative results of MAGE-A gene expression in hematological malignancies have been reported. This led us to study MAGE-A gene expression in human leukemias using RT-PCR
Expression and Mutation of MAGE-A3 mRNA in Lung Cancer Tissues
✍ Scribed by Yue BA; Zhiyuan LI; Weiwei HE; Hao WU; Xuemin CHENG; Donggang ZHUANG; Yiming WU
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 303 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1610-1979
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In a previous analysis, we showed that MAGE‐As were the most frequently expressed cancer‐testis antigens in human bladder tumours. Here, we further characterized by RT‐PCR the expression of this family of genes by analyzing specifically MAGE‐A3, ‐A4, ‐A8 and ‐A9 mRNAs in 46 bladder tumo
The human MAGE gene family encodes products that can be recognized by autologous cytotoxic T cells. Because MAGE genes are silent in most normal tissues except testis but are activated in a variety of neoplastic lesions, MAGE antigens represent ideal targets for immunotherapy. Current knowledge of M
## Abstract 14‐3‐3 Proteins play important roles in a wide range of vital regulatory processes, including signal transduction, apoptosis, cell cycle progression and DNA replication. In mammalian cells, 7 14‐3‐3 isoforms (β, γ, ϵ, η, σ, θ and ζ) have been identified and each of these seems to have d
## Abstract The chromosome region 8p12‐p22 shows frequent allelic loss in a variety of human malignancies, including breast cancer (BC). The tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐receptors TRAIL‐R1, ‐R2, ‐R3 and ‐R4 are located on 8p21‐p22 and might be candidate tumor supp